Immediate Impact

9 standout
Sub-graph 1 of 4

Citing Papers

A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
2025 Standout
1 intermediate paper

Works of Moussa Doumbia being referenced

Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali
2019

Author Peers

Author Last Decade Papers Cites
Moussa Doumbia 64 36 22 13 96
Flanon Coulibaly 62 34 22 12 90
Terese Bekkevold 51 44 23 11 93
Yasser Mandourah 62 62 18 10 183
Anju Shrestha 73 35 10 15 217
Chris Bernart 51 47 14 9 99
Maria Isabel Saraiva Dinelli 83 47 13 13 176
Golubinka Boševska 55 15 16 15 100
Eliseo Pastor-Villalba 104 35 13 18 175
Abián Montesdeoca Melián 97 36 13 17 136
Abdurasiet Mowlana 63 51 58 8 166

All Works

Loading papers...

Rankless by CCL
2026